“Tumour Ablation
Market to Grow at a CAGR of Around 8.2% by 2024” Purchase this report by calling
databridgemarketresearch.com at +1-888-387-2818.
The new report “Global
Tumour Ablation Market”, By Type (Tumour Ablation Systems (Radio Frequency
Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image
Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain,
Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics,
Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest
of the World) – Trends and Forecast to 2024
Report Analysis
The Global Tumour Ablation Market has accounted for USD 1.8
billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR
of 8.2% in the forecast period 2017 to 2024.
This
report consists of below pages:
·
No of pages: 350
·
No of Figures: 60
·
No of Tables: 220
Request For
Free Sample @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market
Report
Definition
The
global tumour ablation market is expected to grow, owing to factors such as
rising cancer incidence, increased focus on treatment of breast cancer, better
reimbursement scenarios, shift towards value based reimbursements and
continuous development in ablation technology. The ablation technology has an
upper edge on chemotherapy and other oncology therapeutics. However ablation
technology can only be used to treat tumours with size less than 3cm, owing to
the healthy tissue damage caused by it. With the advent of guidance mechanisms
such as ultrasounds and MRI the accuracy of the treatment has increased
significantly in the past 5 years.
Market
Segmentation
The global tumour
ablation market is segmented based on product types, cancer types, end-user and
geography.
The global tumour ablation market is segmented into 3 type’s ablation systems,
image guidance products and accessories. The ablation systems dominates the
market and is further segmented based on product type into microwave ablation
(coretherm thermotherapy devices and prolieve thermotherapy devices),
radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled,
catheter manipulation systems), high intensity focused ultrasound (HIFU), laser
ablation and cryoablation.
On the basis of
cancer types treated using ablation devices the market is segmented into liver,
lings, kidney, brain, bone, pancreas, breast and, other cancer types.
Based on end-user
the global tumour ablation market is segmented into hospitals, oncology clinics
and others.
For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-tumour-ablation-market
Geographical Segmentation
Based
on geography the global tumour ablation market is segmented into 5 geographical
regions, North America, Europe, Asia-Pacific, South America and rest of the
world. The geographical regions are further segmented into 24 major countries
such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland,
Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa
and many others. In 2016, Europe is expected to dominate the market with 36.7%
market share, owing to the large incidence of cancer patients in this region
coupled with good reimbursements.
Competitive
Landscape
The tumour ablation market
report major
players have used various strategies such as new product launches, expansions,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. Some examples of recent
strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF
Ablation System from Baylis Medical and received its FDA approval, December,
2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015,
Medtronic acquired Covidien to strengthen its leadership in medical devices
industry among others. The report includes market shares of tumor ablation
market for global, Europe, North America, Asia Pacific and Rest of the World.
In
2015, Medtronic has dominated the global tumour ablation market. Some of the other key players operating in this market are Galil
Medical, Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips
N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc.,
Misonix, Inc., BVM Medical Limited, AngioDynamics, Inc., COMSOL Inc., Boston
Scientific Corporation, EDAP TMS S.A. and, HealthTronics, Inc. among other
companies.
Read more news
about this Report Visit @ http://databridgemarketresearch.com/reports/global-tumour-ablation-market/
Table of
Content:
1.
INTRODUCTION
1.1. OVERVIEW OF THE TUMOUR ABLATION
MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2.
RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE TUMOUR ABLATION
MARKET SIZE
2.3. ASSUMPTIONS
3.
MARKET LANDSCAPE SUMMARY
4.
MARKET OVERVIEW
4.1. OVERVIEW
4.2. TUMOUR ABLATION MARKET: KEY PRIMARY
INSIGHTS
4.3. DRIVERS, OPPORTUNITIES AND THREAT
ANALYSIS MATRIX
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING
TECHNOLOGIES
5.
TUMOUR ABLATION MARKET, BY TYPE
5.1. OVERVIEW
5.2. TUMOUR ABLATION SYSTEMS
5.2.1. RADIO FREQUENCY ABLATION SYSTEM (RFA)
5.2.2. MICROWAVE ABLATION SYSTEM
5.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND
ABLATION SYSTEM (HIFU)
5.2.4. LASER ABLATION SYSTEM
5.2.5. CRYOABLATION
5.3. IMAGE GUIDANCE PRODUCTS
5.4. ACCESSORIES
6.
TUMOUR ABLATION MARKET, BY CANCER TYPE
7.
TUMOR ABLATION MARKET, BY END-USER
7.1.
OVERVIEW
7.2.
HOSPITALS
7.3.
ONCOLOGY CLINICS
7.4.
OTHERS
8.
TUMOUR ABLATION MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE TUMOUR ABLATION MARKET,
(ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.2. KEY PRIMARY INSIGHTS: BY MAJOR
COUNTRIES
9.
TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL TUMOUR ABLATION MARKET:
COMPANY SHARE ANALYSIS
9.2. NORTH AMERICA TUMOUR ABLATION
MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE TUMOUR ABLATION MARKET:
COMPANY SHARE ANALYSIS
9.4. APAC TUMOUR ABLATION MARKET:
COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT &
APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC
DEVELOPMENTS
10.
TUMOUR ABLATION MARKET, COMPANY PROFILES
10.1. MEDTRONIC
10.2. GALIL MEDICAL, INC.
10.3 PERSEON CORPORATION
10.4 NEUWAVE MEDICAL, INC.
10.5. KONINKLIJKE PHILIPS N.V.
10.6. INTIO INC.
10.7. MERMAID MEDICAL A/S
10.8. SONACARE MEDICAL, LLC
10.9. DFINE, INC.
10.10. MISONIX, INC.
10.11. BVM MEDICAL LIMITED
10.12. ANGIODYNAMICS, INC.
10.13. COMSOL INC.
10.14. BOSTON SCIENTIFIC CORPORATION
10.15. EDAP TMS S.A.
10.16. HEALTHTRONICS, INC.
11.
APPENDIX
12.
ABOUT DATA BRIDGE MARKET RESEARCH
Related Report
Global Ablation Devices Market – Trends and Forecast to 2024
Global Ablation
Devices Market, By Technology (Electrical, Radiation, Radiofrequency, Light,
Ultrasound, Cryotherapy, Thermal, Microwave, Hydro-mechanical), By Application
(Cancer, Cardiovascular, Orthopedics, Urology, Gynecology, Ophthalmology and
Others), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest
of the World) – Trends and Forecast to 2024
About Data Bridge
Market Research:
Data Bridge Market Research set forth itself as an
unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best market opportunities and foster efficient information for
your business to thrive in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business challenges and initiates an
effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market
Research
Tel:
+1-888-387-2818
Investor: investors@databridgemarketresearch.com